References
- Gill KK, Kelton JG. Management of idiopathic thrombocytopenic purpura in pregnancy. Semin Hematol 2000; 37: 275–89
- Peleg D, Hunter SK. Perinatal management of women with immune thrombocytopenic purpura; survey of United States perinatologists. Am J Obstet Gynecol 1999; 180: 645–9
- Christiaens GCML, Nieuwenhuis HK, Bussel B. Comparison of platelet counts in first and second newborns of matters with immune thrombocytopenic purpura. Obstet Gynecol 1997; 91: 546–52
- Burrows RF, Kelton JG. Thrombocytopenia during pregnancy. Haemostasis and Thrombosis in Obstetrics and Gynaecologyfirst edition, A Greer, AGG Turpie, CD Forbes. Chapman & Hall, London 1992
- Letsky EA, Greaves M. Guidelines on the investigation and management of thrombocytopenia in pregnancy and neonatal alloimmune thrombocytopenia. Maternal and Neonatal Haemostasis working Party of the Haemostasis and Thrombosis Task force of the British Society for Haematology. Br J Haematol 1996; 95: 21–6
- Salnio S, Joutsi L, Jarvenpaa AL, Kekomaki, Rkoistinen E, Riikonen S, Teramo K. Idiopathic thrombocytopenic purpura in pregnancy. Acta Obstet Gynecol Scand 1998; 77: 272–7
- Boehlen F, Hohlfeld P, Extermann P, de Moerloose P. Maternal antiplatelet antibodies in predicting risk of neonatal thrombocytopenia. Obstet Gynecol 1998; 93: 169–73
- Lichtin A. The ITP practice guideline; what, why, and for whom?. Blood 1996; 88: 1–2
- Webert KE, Mittal R, Sigmin C, Nancy MH, Kelton JG. A retrospective 11 year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood 2003; 102: 4306–11
- Erkman J, Blythe JG. Azathioprine therapy complicated by pregnancy. Obstet Gynecol 1972; 40: 708–10
- Price HV, Salaman JR, Laurence KM, Langmaid H. Immunosuppressive drugs and the foetus. Transplantation 1976; 21: 294–8
- Alstead EM, Ritchie JK, Lennard-Jones JE, Farthling MJ, Clark ML. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology 1990; 99: 443–6
- Murray JM, Harris RE. The management of the pregnant patient with idiopathic thrombocytopenic purpura. Am J Obst Gyn 1976; 126: 449–51
- Bussel JB, Druzin ML, Cines DB, Samuels P. Thrombocytopenia in pregnancy. Lancet 1991; 337: 251
- Al Jama FE, Rahman J, Subiman A, Suleimen AI, Rahman MS. Outcome of pregnancy in women with idiopathic thrombocytopenic purpura. Aust NZ J Obstet Gynecol 1998; 38(4)410
- Samuels P, Bussel JB, Braitman LE, Tomaski A, Druzin ML, Mennuti MT, Cines DB. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura. N Engl J Med 1990; 323: 229–35
- Scioscia AL, Grannum PA, Copel JA, Hobbins JC. The use of percutaneous umbilical blood sampling in immune thrombocytopenic purpura. Am J Obst Gynecol 1988; 159: 1066–8
- Scott JR, Cruikshank DP, Kochenour NK, Pitkin RM, Warenski JC. Fetal platelet counts in the obstetric management of immunologic thrombocytopenic purpura. Am J Obst Gynecol 1980; 136: 495–9